SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-032293
Filing Date
2024-07-02
Accepted
2024-07-02 21:53:20
Documents
1
Period of Report
2024-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 19605
  Complete submission text file 0001140361-24-032293.txt   21143
Mailing Address C/O AYER CAPITAL MANAGEMENT, LP 230 CALIFORNIA ST, SUITE 600 SAN FRANCISCO CA 94111
Business Address
Venkatesan Jay (Reporting) CIK: 0001413350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 241098125

Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)